We conducted a group consensus review of thyroid aspirates that were previously interpreted as ''atypia of undetermined significance/follicular lesion of undetermined significance'' (AUS/ FLUS) and followed by surgical interventions. The study aimed to investigate if consensus review would minimize the diagnosis of AUS/FLUS with an optimal interobserver agreement and also promote a better cytohistologic concordance. A group of reviewers who were blinded to the corresponding histologic findings simultaneously evaluated a total of 50 aspirates at a multiheaded light microscope. Using the Bethesda System for Reporting Thyroid Cytopathology as a guideline, a consensus interpretation was reached upon review of each aspirate. Interobserver agreement was calculated and recorded. The cytohistologic correlation was then performed between the consensus interpretation and the corresponding histologic diagnosis. The consensus review reclassified 26 (52%) aspirates as non-neoplasia/benign, 10 (20%) as follicular neoplasm/suspicious for a follicular neoplasm, 1 (2%) as papillary thyroid carcinoma, and 2 (4%) as nondiagnostic. Eleven (22%) aspirates remained AUS/FLUS. The interobserver agreement across the five diagnostic categories ranged from 71.6% to 100% with an average level of 88.8%. Cytohistologic concordance was achieved in 24 of 26 (92.3%) and 9 of 11 (81.8%) aspirates that were reclassified as nonneoplasia/benign and neoplasia/malignancy, respectively. A diagnostic accuracy of 89.2% (33/37) was obtained in reclassified cases. In conclusion, the group consensus review minimized AUS/ FLUS, offered an optimal level of interobserver agreement, and most importantly, promoted excellent cytohistologic concordance in reclassified cases and, therefore, could play a substantial role in the future in reducing reaspiration and/or unnecessary surgeries.
It has been widely accepted that fine needle aspiration (FNA) of thyroid plays an essential and critical role in the management of thyroid nodules. For the majority of thyroid nodules, FNA cytologic evaluation effectively differentiates neoplastic/malignant nodules requiring surgical intervention from non-neoplastic/benign nodules that may be managed conservatively with clinical and radiologic follow-up. [1] [2] [3] [4] However, in a subset of cases, FNA cytology of thyroid nodules exhibits cytomorphologic features that are neither convincingly non-neoplastic/benign nor sufficient for neoplasia/malignancy, and a definitive cytologic interpretation (non-neoplasia/benign versus neoplasia/ malignancy) cannot be established. Instead, in these cases, an indeterminate interpretation such as ''atypia of undetermined significance/follicular lesion of undetermined significance'' (AUS/FLUS) is rendered. [5] [6] [7] Recognizing the considerable variation among both pathologists and institutions in diagnosing indeterminate lesions, the newly published The Bethesda System for Reporting Thyroid Cytology (BSRTC) defines the diagnostic criteria for AUS/ FLUS and advises judicious use of this diagnostic terminology. 8 FNA of thyroid nodules has been an established practice within our institution. Currently, the cytology service assesses more than 800 thyroid FNA specimens per year, of which nearly 6% are classified as AUS/FLUS. Data from a previous study at our institution demonstrated that using proposed standard morphological criteria similar to those of the BSRTC, in conjunction with independent second review, reduces the diagnosis of AUS/FLUS and improves cytohistologic correlation. 9 The current study was undertaken to investigate if group consensus review would minimize AUS/FLUS diagnoses with optimal interobserver agreement while also promoting a better cytohistologic concordance.
Materials and Methods
A SNOMED search of the electronic pathology database in our institution for the period between January 1998 and June 2010 retrieved a total of 217 aspirates in which the original cytologic interpretation of AUS/FLUS was rendered and that were followed by hemi-or total thyroidectomies. For the retrospective consensus review, 50 aspirates were selected by choosing the first 50 consecutive cases in which a complete set of smears prepared from each aspirate was available. Forty-six of the 50 aspirates consisted of conventional air-dried Diff-Quik and alcoholfixed Papanicolaou smears along with ThinPrep and/or cell block preparations; the remaining four aspirates contained ThinPrep and cell block preparation only. A group of reviewers, who were blinded to the corresponding histologic findings, simultaneously evaluated slides of each aspirate at a multiheaded light microscope. Reviewers were two cytopathology fellows (KH, JP), three junior (with 2-4 years of experience, XJ, SMK, MHR), and three senior cytopathologists (with more than 15 years of experience, RD, RR, CWM). At least five reviewers representing both junior and senior levels participated in the evaluation of each individual aspirate. Using the BSRTC as a guideline, individual interpretation was presented following the ascending order of the reviewer's levels of experience, and a consensus interpretation was then reached at the end of the group review. Interobserver agreement was calculated by dividing diagnosis of the majority by the total. For example, interobserver agreement for an individual aspirate was 100% if all participating reviewers agreed on the cytologic interpretation for an individual aspirate; however, interobserver agreement would decrease to 60% if three out of five participating reviewers concurred with the interpretation, while the other two reviewers disagreed with the interpretation. Mean interobserver agreement was calculated for each category at the end of the study. For each aspirate, the cytohistologic correlation (the consensus interpretation versus the corresponding histologic diagnoses) was performed immediately upon obtaining the consensus cytologic interpretation. Cytologic features of each aspirate were discussed in detail throughout the group consensus review. To assess if reviewers gained positive feedback through the approach of immediate cytohistologic correlation, we excluded two aspirates reclassified as nondiagnostic specimen and then compared performance of the consensus review between earlier (review of first 24 diagnostic aspirates) and later phase (review of last 24 diagnostic aspirates).
Results
Using BSRTC 8 as a guideline, the group consensus review of 50 thyroid aspirates previously interpreted as AUS/ FLUS resulted in reclassification of 26 (52%) aspirates as non-neoplasia/benign, including nodular hyperplasia and chronic lymphocytic thyroiditis, 10 (20%) aspirates as follicular neoplasm/suspicious for a follicular neoplasm (FN/ SFN), 1 (2%) aspirate as papillary thyroid carcinoma (PTC), and 2 (4%) aspirates as nondiagnostic because of the insufficient number of follicular cells. On the other hand, 11 (22%) aspirates remained AUS/FLUS following the group review. The interobserver agreement across the five diagnostic categories ranged from 71.6% for AUS/ FLUS to 100% for PTC and nondiagnostic with an average level of 88.8% (Table I ). Table I also shows correlation between the cytologic interpretations rendered by the group consensus review and the corresponding histologic diagnoses. Cytohistologic concordance was achieved in 24 of 26 (92.3%) and 9 of 11 (81.8%) aspirates that were reclassified as non-neoplasia/benign ( Fig. 1 ) and neoplasia/malignancy (Figs. 2 and 3) , respectively. The histology-proved neoplasia/malignancy included six follicular adenomas and three PTC among which two were follicular variant of PTC. A diagnostic accuracy of 89.2% (33/37) was obtained in the reclassified aspirates. Cytologic misinterpretation during the group review contributed to the false-negative and false-positive interpretations. Dividing the study period into earlier (review of first 24 diagnostic aspirates) and later phase (review of last 24 diagnostic aspirates), 20 and 13 aspirates with cytohistologic concordance were reviewed during later and earlier phase of the study, respectively; all four aspirates with cytohistologic discordance were reassessed during the early phase of the group review. Additionally, out of 11 aspirates remained as AUS/FLUS, 7 and 4 aspirates were results of earlier and later group review, respectively (Table II) . Histologic examination of the 11 aspirates remaining as AUS/FLUS revealed five benign diagnoses, three follicular adenomas, two follicular carcinomas, and one conventional PTC. Thus, malignancy was detected in corresponding surgical specimens in 27% (3/11) of the remaining indeterminate aspirates.
Discussion
Profound variations among both pathologists (i.e., 2.5-28.6%) and institutions (i.e., 3.3-14.9%) have been previously described with regard to applying the indeterminate diagnostic terminology for FNA cytology evaluation of thyroid nodules. 10 One of the dominant contributing factors leading to the variation is the lack of precisely defined, objective morphological criteria. [10] [11] [12] In addition, threshold level and stringency in applying the diagnostic criteria may differ among reviewers and institutions. According to the newly published BSRTC, 8 AUS/FLUS is mainly reserved for aspirates with architectural and/or cytologic atypia that is not sufficient to be categorized as suspicious for neoplasia/malignancy, yet on the other hand, is more marked than can be ascribed confidently to benign changes. BSRTC recommends the indeterminate interpretation be used in <7% of all thyroid FNA interpretation and suggests clinical correlation and repeat aspiration after an appropriate interval following initial indeterminate interpretation. 8 In our institution, nearly 6% of all thyroid aspirates fall into the indeterminate category during the last 12 years. On the other hand, virtually all thyroid nodules categorized as AUS/FLUS at our institution were managed with surgical interventions prior to the implementation of the newly published BSRTC recommendation.
Our data demonstrates that using BSRTC as a guideline, group consensus review of the aspirates previously categorized as AUS/FLUS: (1) minimizes AUS/FLUS without compromising diagnostic accuracy; (2) achieves an optimal level of interobserver agreement; and (3) promotes a better cytohistologic concordance and diagnostic accuracy. Overall, the group consensus review could have played a substantial role in reducing unnecessary surgical intervention, and more than 90% of non-neoplastic/benign thyroid nodules could have been managed with clinical/ radiological follow-up instead of surgical intervention.
In comparison to results of our previously published data generated from the individualized second review of 123 indeterminate thyroid aspirates, 9 the current data illustrates an identical distribution in the diagnostic categories of both non-neoplasia/benign (52%) and neoplasia/ malignancy (22%). The percentage of remaining AUS/ FLUS in the current study (22%) appears to be slightly lower than that of prior study (26%). We thus believe that previously categorized indeterminate lesions in our institution were well-represented by the 50 aspirates in the study. However, it is noteworthy that a more accurate cytohistologic concordance is achieved in the current study for both non-neoplasia/benign (92.3% versus 73.4%) and neoplasia/malignancy (81.8% versus 55.6%). Thus, the current data demonstrates a higher level of diagnostic accuracy for reclassified aspirates (89.2% versus 68.1%). Considering that both studies employed similar cytomorphologic criteria as a guideline, we suggest that in addition to the approach of consensus review itself, positive feedback obtained through cytohistologic correlation performed immediately upon completion of the group review of each aspirate played a significant role in realtime affirmation of the diagnostic cytologic features. In this regard, it is interesting to see that later phase of the study generated more cytohistologic concordant cases (n ¼ 20) compared with earlier phase (n ¼ 13), none of the cytohistologic discordant cases occurred during the later phase and furthermore, later phase of the study generated less AUS/FLUS (n ¼ 4) compared with earlier phase (n ¼ 7). We believe that the group consensus review along with a consistent and effective feedback contributed to marked improvement in diagnostic accuracy. In fact, diagnostic accuracy obtained in the current study is compatible to the previously reported data, which were generated from a study of general cohort of thyroid aspirates. 13 The findings support our postulate that the refined consensual approach combined with a consistent and effective feedback brings enhanced accuracy in the categorization of the thyroid lesions that pose diagnostic challenges.
With regard to assessing influence of reviewer's experience on classifying aspirates as AUS/FLUS, we were fully aware that different conclusions were drawn from the studies that used different approaches. For example, a review of original cytology reports from multi-institutions did not show a relationship between the level of reviewer's experience and usage of the indeterminate terminology, 10 while a cytologic re-review of previously diagnosed indeterminate lesions demonstrated less usage of the indeterminate terminology by the reviewers with more experience. 11 We believed that it is unlikely to generate additional information by applying the similar approaches to our existing cohort of AUS/FLUS. Thus, the current study focused on the role of group consensus review in the reassessment of previously categorized indeterminate aspirates. Before reaching a consensus interpretation for each aspirate, individual interpretation was presented following the ascending order of the reviewer's levels of experience so that the junior reviewers made their decision without being influenced by the senior reviewers. Noting that the reassessment was performed on the thyroid lesions with diagnostic challenges, the interobserver agreement across the diagnostic categories descended in the following order: malignant PTC (100%) > non-neoplasia/benign (90.5%) > FN/SFN (81.8%) > AUS/FLUS (71.6%). Not surprisingly, the least interobserver agreement was obtained for the category of AUS/FLUS. Different approaches are explored for further stratification of thyroid lesions categorized as AUS/FLUS. In this regard, potential benefit of applying molecular analysis as an adjunct of FNA cytology has been investigated. 14, 15 Regardless, the cytomorphologic assessment is an essential and critical, as well as a cost-effective, method in the management of thyroid nodules.
In conclusion, the group consensus review minimized AUS/FLUS, offered an optimal level of interobserver agreement, and most importantly, promoted excellent cytohistologic concordance in reclassified cases and, therefore, could play a substantial role in the future in reducing reaspiration and/or unnecessary surgeries. 
